Drugs & OTC

Cann Global Limited (ASX:CGB) Quarterly Activities and Cashflow Report

🕔8/3/2020 8:06:52 AM

Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report

🕔7/29/2020 10:29:44 AM

While focussing financial resources on development of GaRP, Anatara has been evaluating development, in collaboration with third parties, additional dosage forms for piglets and to utilise Anatara's intellectual property in other species including in-feed formulations for piglets, formulations for aquaculture and formulations for poultry.

Read Full Article

Cann Global Limited (ASX:CGB) Entitlement Issue Update and Shortfall Notification

🕔7/28/2020 7:14:24 PM

Cann Global Limited (ASX:CGB) is pleased to confirm that the 1 for 4 renounceable entitlement offer announced on 3 July 2020 (Entitlement Offer), closed on Thursday 23 July 2020.

Read Full Article

Cann Global Limited (ASX:CGB) Rights Issue Update

🕔7/10/2020 4:52:02 PM

Cann Global Ltd (ASX:CGB) today confirms that its Directors and largest shareholders intend to participate in the rights issues announced on 3 July 2020.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Partnering Update

🕔6/23/2020 1:04:50 PM

Anatara is nearing conclusion of a process of due diligence and negotiation with many of the world's leading animal health companies. Anatara's objective being to partner with a company or companies to register Detach(R) in key overseas markets.

Read Full Article

Cann Global Limited (ASX:CGB) Research Results Lead to Broader Auto-immune Research

🕔6/15/2020 10:11:11 AM

Cann Global Limited's (ASX:CGB) medical Cannabis research division, Medical Cannabis Research Group Pty Ltd (MCRG) entered into a research agreement to research the possibility of the use of cannabis in the treatment of autoimmune disease, specifically multiple sclerosis (MS).

Read Full Article

Cann Global Limited (ASX:CGB) Cann Global Asia Update

🕔6/15/2020 9:36:50 AM

The Board of Cann Global Limited (ASX:CGB) wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR.

Read Full Article